arginyl-glycyl-aspartic acid has been researched along with Bladder Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Han, R; Hao, Y; He, X; Liu, Q; Liu, T; Qian, Z; Yang, C; Yang, Y | 1 |
| Arai, Y; Cai, Z; Li, D; Luo, J; Satoh, M; Wang, H; Yang, F | 1 |
| Chu, L; Liu, XY; Shen, J; Wu, S; Xiao, J; Xu, H; Xu, Y; Yang, Y | 1 |
| Liu, XW; Liu, YQ; Niu, HT; Song, YF; Tian, YX; Wang, DG; Zhao, MJ | 1 |
| Araldi, EM; Belvisi, L; Civera, M; Potenza, D; Vasile, F | 1 |
| Acharya, B; Gotoh, A; Hamada, K; Hiwasa, K; Mizuguchi, H; Nagaya, H; Terao, S | 1 |
| Choi, JC; Liu, BC; Margolis, EJ; Shu, WP | 1 |
7 other study(ies) available for arginyl-glycyl-aspartic acid and Bladder Cancer
| Article | Year |
|---|---|
RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
Topics: Cell Line, Tumor; Glutathione; Humans; Nanoparticles; Oligopeptides; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Platinum; Polyethylene Glycols; Prodrugs; Tumor Microenvironment; Urinary Bladder Neoplasms | 2023 |
Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Genetic Therapy; Humans; Integrins; Mice; Mice, Inbred BALB C; Oligopeptides; Receptors, Virus; Urinary Bladder Neoplasms | 2014 |
RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.
Topics: Adenoviruses, Human; Animals; Apoptosis; Cell Transformation, Neoplastic; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Female; Genetic Therapy; Green Fluorescent Proteins; Humans; Integrin alphaV; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Oligopeptides; Oncolytic Viruses; Spheroids, Cellular; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
Topics: Adenoviridae; Apoptosis; Cell Line, Tumor; Ganciclovir; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Oligopeptides; Thymidine Kinase; Urinary Bladder Neoplasms; Uroplakin II | 2016 |
STD and trNOESY NMR study of receptor-ligand interactions in living cancer cells.
Topics: Cell Line, Tumor; Humans; Integrin alpha Chains; Integrin beta Chains; Ligands; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Oligopeptides; Protein Binding; Urinary Bladder Neoplasms | 2011 |
Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
Topics: Adenoviridae; Base Sequence; Cell Line, Tumor; Coxsackie and Adenovirus Receptor-Like Membrane Protein; DNA Primers; Genetic Therapy; Genetic Vectors; Humans; Integrins; Oligopeptides; Real-Time Polymerase Chain Reaction; Receptors, Virus; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transduction, Genetic; Urinary Bladder Neoplasms | 2012 |
Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer.
Topics: Amino Acid Sequence; Binding Sites; Cell Movement; Chemotaxis; Enzyme Activation; Fibronectins; Humans; Molecular Sequence Data; Oligopeptides; Protein Kinase C; Sensitivity and Specificity; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1996 |